Sanome is a London-based health startup that has developed a diagnostics innovation engine combining biomarkers to produce medical-grade, at-home diagnostic products (IVDs). The company’s home tests are clinically validated and aim to improve patient outcomes and reduce healthcare costs. Sanome plans to develop and validate a first set of IVD candidates through strategic and commercial partnerships. The recent funding will be used to expand the team across London, Amsterdam, and Cambridge and to deliver on key strategic and commercial partnerships. The company was founded by Benedikt von Thüngen (CEO) and Dr Marc van der Schee (Chief Medical Officer). Sanome raised £2m in its first round of funding to support these plans.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2021